Genetic and environmental determinants of hepatocyte growth factor levels and their association with obesity and blood pressure

Annals of Human Biology

Volumn 35, Issue 1, 2008, Pages 93-103

  Vistoropsky, Yulia ^a   Trofimov, Svetlana ^a   Malkin, Ida ^a   Kobyliansky, Eugene ^a   Livshits, Gregory ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Genetic correlations; Heritability; HGF; Hypertension; WHR

Indexed keywords

SCATTER FACTOR;

BLOOD; BODY MASS; ENVIRONMENTAL FACTOR; GENETICS; GROWTH; HERITABILITY; HYPERTENSION; OBESITY; PHENOTYPE;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; ENVIRONMENT; EPIDEMIOLOGY; FEMALE; GENETICS; HUMAN; HYPERTENSION; ISRAEL; LIFESTYLE; MALE; MIDDLE AGED; MONITOR; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PILOT STUDY; RISK FACTOR; SIBLING; SYSTOLE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BLOOD PRESSURE; BLOOD PRESSURE MONITORS; BODY MASS INDEX; ENVIRONMENT; EPIDEMIOLOGIC STUDIES; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPERTENSION; ISRAEL; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; PILOT PROJECTS; RISK FACTORS; SIBLINGS; SYSTOLE;

EID: 39349090237     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.1080/03014460701822003     Document Type: Article

References (40)

1. Bell LN, Ward JL, Degawa-Yamauchix M, Bovenkerk JE, Jones R, Cacucci BM, Gupta CE, Sheridan C, Sheridan K, Shankar SS, et al. 2006. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab 291:E843-E848.
2. Boros P, Miller CM. 1995. Hepatocyte growth factor: A multifunctional cytokine. Lancet 345:293-295.
3. Bray GA, Bellanger T. 2006. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29:109-117.
4. Butte NF, Comuzzie AG, Cai G, Cole SA, Mehta NR, Bacino CA. 2005. Genetic and environmental factors influencing fasting serum adiponectin in Hispanic children. J Clin Endocrinol Metab 90:4170-4176.
5. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA, AusDiab Steering Committee. 2003. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 254:555-563.
6. Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, Black AE, Maas D, Takahashi M, Kihara S, Tanaka S, et al. 2001. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity, and the metabolic syndrome. J Clin Endocrinol Metab 86:4321-4325.
7. Fain JN. 2006. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74:443-477.
8. Farooqi IS, O'Rahilly S. 2000. Recent advances in the genetics of severe childhood obesity. Arch Dis Child 83:31-34.
9. Feuerherm AJ, Borset M, Seidel C, Sundan A, Leistad L, Ostensen M, Faxvaag A. 2001. Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. Scand J Rheumatol 30:229-234.
10. Gohda E, Matsunaga T, Kataoka H, Yamamoto I. 1992. TGF-beta is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts. Cell Biol Int Rep 16:917-926.
11. Hayashi Y, Saitoh S, Takagi S, Tuchihashi K, Miura T, Shimamoto K. 2002. Hepatocyte growth factor and 24-hour ambulatory blood pressure monitoring. Hypertens Res 25:655-660.
12. Hiratsuka A, Adachi H, Fujiura Y. 2005. Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab 90:2927-2931.
13. Huerta MG. 2006. Adiponectin and leptin: Potential tools in the differential diagnosis of pediatric diabetes? Rev Endocr Metab Disord 7:187-196.
14. Jiang JG, Gao B, Zarnegar R. 2000. The concerted regulatory functions of the transcription factors nuclear factor-1 and upstream stimulatory factor on a composite element in the promoter of the hepatocyte growth factor gene. Oncogene 19:2786-2790.
15. Lamblin N, Susen S, Dagorn J, Mouquet F, Jude B, Van Belle E, Bauters C, de Groote P. 2005. Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J 150:137-143.
16. Livshits G, Gerber LM. 2001. Familial factors of blood pressure and adiposity covariation. Hypertension 37:928-935.
17. Livshits G, Ginsburg E, Kobyliansky E. 1999. Heterogeneity of genetic control of blood pressure in ethnically different populations. Hum Biol 71:685-708.
18. Livshits G, Karasik D, Kobyliansky E. 2002. Complex segregation analysis of the radiographic phalanges bone mineral density and their age-related changes. J Bone Miner Res 17:152-161.
19. Livshits G, Pantsulaia I, Gerber LM. 2005. Association of leptin levels with obesity and blood pressure: Possible common genetic variation. Int J Obes 29:85-92.
20. Livshits G, Pantsulaia I, Trofimov S, Kobyliansky E. 2003. Genetic variation of circulating leptin is involved in genetic variation of hand bone size and geometry. Osteoporos Int 14:476-483.
21. Livshits G. 2006. Quantitative genetics of circulating molecules associated with bone metabolism: A review. J Musculoskelet Neuronal Interact 6:47-61.
22. Malkin I, Ginsburg E. 2007. Program package for pedigree analysis (version MAN-7). Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv University, Technical Report.
23. Mikroulis D, Papanas N, Maltezos E, Bougioukas G. 2007. Angiogenic growth factors in the treatment of peripheral arterial disease. Curr Vasc Pharmacol 5:195-209.
24. Morishita R, Aoki M, Yo Y, Ogihara T. 2002. Hepatocyte growth factor as cardiovascular hormone: Role of HGF in the pathogenesis of cardiovascular disease. Endocr J 49:273-284.
25. Motone M, Katsuya T, Ishikawa K, Iwashima Y, Iwashima Y, Sugimoto K, Yamamoto K, Fu Y, Matsuo A, Ohishi M, et al. 2004. Association between hepatocyte growth factor gene polymorphism and essential hypertension. Hypertens Res 27:247-251.
26. Nakamura S, Moriguchi A, Morishita R, Aoki M, Yo Y, Hayashi S, Nakano N, Katsuya T, Nakata S, Takami S, et al. 1998. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem Biophys Res Commun 242:238-243.
27. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, Tracy RP. 2001. Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis 154:681-689.
28. Rehman J, Considine RV, Bovenkerk JE, Li J, Slavens CA, Jones RM, March KL. 2003. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 41:1408-1413.
29. Retterstol L, Eikvar L, Berg K. 2003. A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease. Atherosclerosis 169:2279-2282.
30. Robak E, Wozniacka A, Sysa-Jedrzejowska A, Stepien H, Robak T. 2001. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity. Eur Cytokine Netw 12:445-452.
31. Ronti T, Lupattelli G, Mannarino E. 2006. The endocrine function of adipose tissue: An update. Clin Endocrinol 64:355-365.
32. Scherer PE. 2006. Adipose tissue: From lipid storage compartment to endocrine organ. Diabetes 55:1537-1545.
33. See R, Abdullah SM, McGuire DK, Khera A, Patel MJ, Lindsey JB, Grundy SM, de Lemos JA. 2007. The association of differing measures of overweight and obesity with prevalent atherosclerosis: The Dallas Heart Study. J Am Coll Cardiol 50:752-759.
34. Shmulewitz D, Heath SC, Blundell ML, Han Z, Sharma R, Salit J, Auerbach SB, Signorini S, Breslow JL, Stoffel M, et al. 2006. Linkage analysis of quantitative traits for obesity, diabetes, hypertension, and dyslipidemia on the island of Kosrae, Federated States of Micronesia. Proc Natl Acad Sci USA 103:3502-3509.
35. Sturm R. 2002. The effects of obesity, smoking, and problem drinking on chronic medical problems and health care costs. Health Affairs 21:245-253.
36. Swierczynski J, Korczynska J, Goyke E. 2005. Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty. Obes Surg 15:803-808.
37. Visscher TL, Kromhout D, Seidell JC. 2002. Long-term and recent time trends in the prevalence of obesity among Dutch men and women. Int J Obes Relat Metab Disord 26:1218-1224.
38. Wallace AM, Banfield E, Ingram M. 2004. Glucocorticoids contribute to the heritability of leptin in Scottish adult female twins. Clin Endocrinol 61:149-154.
39. Walley AJ, Blakemore AI, Froguel P. 2006. Genetics of obesity and the prediction of risk for health. Hum Mol Genet 15:R124-30.
40. Zarnegar R. 1995. Regulation of HGF and HGFR gene expression. EXS 74:33-49.